Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2018

Open Access 01-05-2018 | Lipidomics

Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics

Authors: Katharina Herzog, Mia L. Pras-Raves, Sacha Ferdinandusse, Martin A. T. Vervaart, Angela C. M. Luyf, Antoine H. C. van Kampen, Ronald J. A. Wanders, Hans R. Waterham, Frédéric M. Vaz

Published in: Journal of Inherited Metabolic Disease | Issue 3/2018

Login to get access

Abstract

Peroxisomes play an important role in a variety of metabolic pathways, including the α- and β-oxidation of fatty acids, and the biosynthesis of ether phospholipids. Single peroxisomal enzyme deficiencies (PEDs) are a group of peroxisomal disorders in which either a peroxisomal matrix enzyme or a peroxisomal membrane transporter protein is deficient. To investigate the functional consequences of specific enzyme deficiencies on the lipidome, we performed lipidomics using cultured skin fibroblasts with different defects in the β-oxidation of very long-chain fatty acids, including ABCD1- (ALD), acyl-CoA oxidase 1 (ACOX1)-, D-bifunctional protein (DBP)-, and acyl-CoA binding domain containing protein 5 (ACBD5)-deficient cell lines. Ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry revealed characteristic changes in the phospholipid composition in fibroblasts with different fatty acid β-oxidation defects. Remarkably, we found that ether phospholipids, including plasmalogens, were decreased. We defined specific phospholipid ratios reflecting the different enzyme defects, which can be used to discriminate the PED fibroblasts from healthy control cells.
Appendix
Available only for authorised users
Literature
go back to reference Gromski PS, Muhamadali H, Ellis DI et al (2015) A tutorial review: metabolomics and partial least squares-discriminant analysis - a marriage of convenience or a shotgun wedding. Anal Chim Acta 879:10–23 Gromski PS, Muhamadali H, Ellis DI et al (2015) A tutorial review: metabolomics and partial least squares-discriminant analysis - a marriage of convenience or a shotgun wedding. Anal Chim Acta 879:10–23
go back to reference Houtkooper RH, Vaz FM (2008) Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 65:2493–2506CrossRefPubMed Houtkooper RH, Vaz FM (2008) Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci 65:2493–2506CrossRefPubMed
go back to reference Kayganich KA, Murphy RC (1992) Fast atom bombardment tandem mass spectrometric identification of diacyl, alkylacyl, and alk-1-enylacyl molecular species of glycerophosphoethanolamine in human polymorphonuclear leukocytes. Anal Chem 64:2965–2971CrossRefPubMed Kayganich KA, Murphy RC (1992) Fast atom bombardment tandem mass spectrometric identification of diacyl, alkylacyl, and alk-1-enylacyl molecular species of glycerophosphoethanolamine in human polymorphonuclear leukocytes. Anal Chem 64:2965–2971CrossRefPubMed
go back to reference Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta 1822:1465–1474CrossRefPubMed Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta 1822:1465–1474CrossRefPubMed
go back to reference Poll-The BT, Gärtner J (2012) Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochim Biophys Acta 1822:1421–1429CrossRefPubMed Poll-The BT, Gärtner J (2012) Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochim Biophys Acta 1822:1421–1429CrossRefPubMed
go back to reference Schrakamp G, Schalkwijk CG, Schutgens RB et al (1988) Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res 29:325–334PubMed Schrakamp G, Schalkwijk CG, Schutgens RB et al (1988) Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res 29:325–334PubMed
go back to reference Su HM, Moser AB, Moser HW, Watkins PA (2001) Peroxisomal straight-chain Acyl-CoA Oxidase and D-bifunctional protein are essential for the Retroconversion step in Docosahexaenoic acid synthesis. J Biol Chem 276:38115–38120. doi:10.1074/jbc.M106326200 PubMedCrossRef Su HM, Moser AB, Moser HW, Watkins PA (2001) Peroxisomal straight-chain Acyl-CoA Oxidase and D-bifunctional protein are essential for the Retroconversion step in Docosahexaenoic acid synthesis. J Biol Chem 276:38115–38120. doi:10.​1074/​jbc.​M106326200 PubMedCrossRef
go back to reference Thévenot EA, Roux A, Xu Y et al (2015) Analysis of the human adult urinary Metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for Univariate and OPLS statistical analyses. J Proteome Res 14:3322–3335. doi:10.1021/acs.jproteome.5b00354 CrossRefPubMed Thévenot EA, Roux A, Xu Y et al (2015) Analysis of the human adult urinary Metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for Univariate and OPLS statistical analyses. J Proteome Res 14:3322–3335. doi:10.​1021/​acs.​jproteome.​5b00354 CrossRefPubMed
go back to reference Van Roermund CWT, Visser WF, Ijlst L et al (2011) Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid ß-oxidation. Biochim Biophys Acta 1811:148–152. doi:10.1016/j.bbalip.2010.11.010 Van Roermund CWT, Visser WF, Ijlst L et al (2011) Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid ß-oxidation. Biochim Biophys Acta 1811:148–152. doi:10.​1016/​j.​bbalip.​2010.​11.​010
go back to reference Vreken P, Van Lint AEM, Bootsma AH et al (1998) Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J Chromatogr B Biomed Appl 713:281–287. doi:10.1016/S0378-4347(98)00186-8 CrossRef Vreken P, Van Lint AEM, Bootsma AH et al (1998) Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J Chromatogr B Biomed Appl 713:281–287. doi:10.​1016/​S0378-4347(98)00186-8 CrossRef
go back to reference Yagita Y, Shinohara K, Abe Y et al (2017) Deficiency of a retinal dystrophy protein, Acyl-CoA binding domain-containing 5 (ACBD5), impairs Peroxisomal β-oxidation of very-long-chain fatty acids. J Biol Chem 292:691–705. doi:10.1074/jbc.M116.760090 CrossRefPubMed Yagita Y, Shinohara K, Abe Y et al (2017) Deficiency of a retinal dystrophy protein, Acyl-CoA binding domain-containing 5 (ACBD5), impairs Peroxisomal β-oxidation of very-long-chain fatty acids. J Biol Chem 292:691–705. doi:10.​1074/​jbc.​M116.​760090 CrossRefPubMed
Metadata
Title
Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics
Authors
Katharina Herzog
Mia L. Pras-Raves
Sacha Ferdinandusse
Martin A. T. Vervaart
Angela C. M. Luyf
Antoine H. C. van Kampen
Ronald J. A. Wanders
Hans R. Waterham
Frédéric M. Vaz
Publication date
01-05-2018
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2018
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0076-9

Other articles of this Issue 3/2018

Journal of Inherited Metabolic Disease 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.